about
Structure-Based Discovery of 4-(6-Methoxy-2-methyl-4-(quinolin-4-yl)-9H-pyrimido[4,5-b]indol-7-yl)-3,5-dimethylisoxazole (CD161) as a Potent and Orally Bioavailable BET Bromodomain Inhibitor.Discovery of a Small-Molecule Degrader of Bromodomain and Extra-Terminal (BET) Proteins with Picomolar Cellular Potencies and Capable of Achieving Tumor Regression.Rh(III)-catalyzed Redox-Neutral Unsymmetrical C-H Alkylation and Amidation Reactions of N-Phenoxyacetamides.High-Affinity Peptidomimetic Inhibitors of the DCN1-UBC12 Protein-Protein Interaction.Rhodium(III)-Catalyzed Selective C-H Acetoxylation and Hydroxylation Reactions.Structure-Based Discovery of CF53 as a Potent and Orally Bioavailable Bromodomain and Extra-Terminal (BET) Bromodomain InhibitorDiscovery of QCA570 as an Exceptionally Potent and Efficacious Proteolysis Targeting Chimera (PROTAC) Degrader of the Bromodomain and Extra-Terminal (BET) Proteins Capable of Inducing Complete and Durable Tumor RegressionDiscovery of 8-Methyl-pyrrolo[1,2-a]pyrazin-1(2H)-one Derivatives as Highly Potent and Selective Bromodomain and Extra-Terminal (BET) Bromodomain InhibitorsDiscovery of Highly Potent, Selective, and Orally Efficacious p300/CBP Histone Acetyltransferases InhibitorsRuthenium(II)-Catalyzed Regioselective Ortho C-H Allenylation of Electron-Rich Aniline and Phenol Derivatives
P50
Q38705236-7E0378D1-D5F3-4B43-9BEA-69A1DB620BC4Q38710711-BC478CF9-D83E-4721-BD69-7BB6358E7402Q46259654-03DAF867-6661-43C3-B451-571A53F6B9D4Q50041187-F23F43C5-B443-437E-9BD0-CE13181FC70AQ50579111-C6590441-0B35-4B18-96FC-06FF449689D9Q90274820-DCFF3A1F-1ABE-49CD-B498-02564C6A39A3Q90308978-5CBF20FC-8DE7-48DE-9C4D-F8E4E006C66EQ90624075-AC340F98-9BB5-47D7-8E49-8996464B9031Q92470768-5975B31D-4464-4D48-B13F-21884D0F18EFQ92489880-22FF7E88-572C-4841-B32B-CF9512CB471F
P50
description
researcher (ORCID 0000-0003-1813-8035)
@en
name
Bing Zhou
@en
type
label
Bing Zhou
@en
prefLabel
Bing Zhou
@en
P31
P496
0000-0003-1813-8035